| Primary |
| Eyelid Oedema |
25.0% |
| Mania |
25.0% |
| Parkinson's Disease |
25.0% |
| Pemphigus |
25.0% |
|
| Condition Aggravated |
25.0% |
| Gouty Tophus |
25.0% |
| Mania |
25.0% |
| Urticaria |
25.0% |
|
| Secondary |
| Rheumatoid Arthritis |
35.0% |
| Product Used For Unknown Indication |
12.3% |
| Asthma |
8.6% |
| Systemic Lupus Erythematosus |
5.8% |
| Duchenne Muscular Dystrophy |
4.9% |
| Drug Use For Unknown Indication |
4.6% |
| Juvenile Idiopathic Arthritis |
4.0% |
| Interstitial Lung Disease |
3.1% |
| Mixed Connective Tissue Disease |
2.5% |
| Prophylaxis |
2.1% |
| Bone Disorder |
1.8% |
| Depression |
1.8% |
| Immunosuppressant Drug Therapy |
1.8% |
| Lung Transplant |
1.8% |
| Oral Surgery |
1.8% |
| Pulmonary Fibrosis |
1.8% |
| Gastritis |
1.5% |
| Hypertension |
1.5% |
| Immunosuppression |
1.5% |
| Nausea |
1.5% |
|
| Weight Increased |
14.3% |
| Cellulitis |
9.5% |
| Delayed Puberty |
9.5% |
| Toxic Epidermal Necrolysis |
6.3% |
| Ultrasound Antenatal Screen Abnormal |
6.3% |
| Drug Interaction |
4.8% |
| Inappropriate Antidiuretic Hormone Secretion |
4.8% |
| Local Swelling |
4.8% |
| Strongyloidiasis |
4.8% |
| Anaemia |
3.2% |
| Asphyxia |
3.2% |
| Asthenia |
3.2% |
| Cerebral Ventricle Dilatation |
3.2% |
| Diabetes Mellitus |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Drug-induced Liver Injury |
3.2% |
| Failure To Thrive |
3.2% |
| Hepatitis B |
3.2% |
| Hepatitis B Dna Increased |
3.2% |
| Hypersensitivity |
3.2% |
|
| Concomitant |
| Rheumatoid Arthritis |
38.5% |
| Product Used For Unknown Indication |
16.6% |
| Drug Use For Unknown Indication |
11.0% |
| Hypertension |
7.3% |
| Pain |
4.0% |
| Prophylaxis |
3.4% |
| Asthma |
2.9% |
| Osteoporosis |
2.6% |
| Diabetes Mellitus |
2.0% |
| Depression |
1.8% |
| Ankylosing Spondylitis |
1.6% |
| Arthritis |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Gastric Disorder |
1.2% |
| Rhinitis |
0.8% |
| Crohn's Disease |
0.8% |
| Premedication |
0.7% |
| Renal Transplant |
0.7% |
| Systemic Lupus Erythematosus |
0.7% |
| Vitamin Supplementation |
0.7% |
|
| Weight Decreased |
12.3% |
| Vomiting |
8.5% |
| Pyrexia |
7.7% |
| Sepsis |
6.5% |
| Weight Increased |
6.2% |
| Urinary Tract Infection |
5.8% |
| Septic Shock |
5.4% |
| Rheumatoid Arthritis |
5.0% |
| Pain |
4.6% |
| Pneumonia |
4.2% |
| Respiratory Failure |
4.2% |
| White Blood Cell Count Decreased |
3.8% |
| Pain In Extremity |
3.5% |
| Pleural Effusion |
3.5% |
| Rash |
3.5% |
| Red Blood Cell Sedimentation Rate Increased |
3.5% |
| Visual Impairment |
3.5% |
| Pruritus |
3.1% |
| Pathological Fracture |
2.7% |
| Sputum Culture Positive |
2.7% |
|
